Stay updated on Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2; previous notices including v3.4.1 and funding/operational status messages have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:22:27.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a notice about potential data delays due to a funding lapse. Updated site revision tag from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:37:55.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The update includes small UI/text changes such as showing a glossary toggle reference and a new revision indicator (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:21:44.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to core study content, eligibility criteria, or results information were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:41:02.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Footer updates include adding a 'Revision: v3.3.3' notice and removing the 'HHS Vulnerability Disclosure' link as well as 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T10:22:28.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 in the page footer; no substantive changes to the study content or details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:22:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.